|
gptkbp:instanceOf
|
gptkb:drug
hormone
synthetic progestin
|
|
gptkbp:ATCCode
|
G03AC01
|
|
gptkbp:CASNumber
|
68-23-5
|
|
gptkbp:combines
|
gptkb:mestranol
|
|
gptkbp:countryWithdrawing
|
gptkb:Australia
gptkb:Canada
gptkb:United_Kingdom
gptkb:United_States
|
|
gptkbp:developedBy
|
gptkb:Frank_B._Colton
gptkb:G._D._Searle_&_Company
|
|
gptkbp:eliminationHalfLife
|
5-13 hours
|
|
gptkbp:firstOralContraceptive
|
true
|
|
gptkbp:hasMolecularFormula
|
C20H26O2
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
norethynodrel
|
|
gptkbp:introducedIn
|
1956
|
|
gptkbp:IUPACName
|
17α-ethynyl-17-hydroxy-5(10)-estren-3-one
|
|
gptkbp:legalStatus
|
withdrawn
|
|
gptkbp:marketedAs
|
gptkb:Enovid
Conovid
Enavid
|
|
gptkbp:MeSH_ID
|
D009638
|
|
gptkbp:metabolism
|
hepatic
|
|
gptkbp:pregnancyCategory
|
X (contraindicated)
|
|
gptkbp:PubChem_CID
|
6236
5999
|
|
gptkbp:relatedTo
|
gptkb:norethisterone
ethinylestradiol
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:sideEffect
|
nausea
headache
breast tenderness
thromboembolism
|
|
gptkbp:UNII
|
6M1Y5VY53L
|
|
gptkbp:usedFor
|
contraception
menstrual disorders
|
|
gptkbp:withdrawn
|
1988
|
|
gptkbp:bfsParent
|
gptkb:Enovid
|
|
gptkbp:bfsLayer
|
7
|